Researcher
Robert Colebunders
- Research Expertise:Training and providing advice in the field of infectious diseases, tropical medicine, travel medicine and HIV infection and assistance in establishing national treatment guidelines in these domains.
- Keywords:TUBERCULOSIS, INFECTIOUS DISEASES, HAEMORRAGHIC FEVER, HIV-INFECTION, TROPICAL DISEASE, Medicine
- Disciplines:Immunology, Tropical medicine, Microbiology
- Research techniques:Treatment guidelines.
- Users of research expertise:- Physicians - Medical students - Clinical researchers - Ministry of Health
Affiliations
- Global Health Institute (GHI) (Research group)
Member
From1 Jan 2019 → Today - Epidemiology and social medicine (ESOC) (Research group)
Member
From1 Oct 2014 → 31 Dec 2018 - Epidemiology and social medicine (ESOC) (Research group)
Member
From1 Oct 2003 → 30 Sep 2014
Projects
1 - 10 of 11
- Reducing onchocerciasis-associated morbidity in children.From1 Nov 2022 → TodayFunding: FWO junior postdoctoral fellowship
- Project in the field of Onchocerciasis diagnosis.From1 Jun 2022 → TodayFunding: Foreign foundations, funds with scientific view
- Stopping the burden of disease caused by onchocerciasis-associated epilepsy.From1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
- The assessment of psycho-social and behavioral response and compliance to restriction measures to prevent and control of Covid-19: an series of rapid surveys.From21 Jan 2021 → 20 Jan 2024Funding: Foreign public sponsor
- Effective information exchange and care orientation in Covid-19-related contact tracing phone calls. An applied sociolinguistic and conversation analytic enquiry into optimizing interactional dynamics and pragmatic awareness.From1 Nov 2020 → 31 Oct 2021Funding: FWO Special Call for Covid-19 research projects
- African network to study, treat and prevent onchocerciasis associated epilepsy (OAE-Africa).From1 Jan 2019 → 31 Aug 2022Funding: VLIR-UOS Joint
- Multi-disciplinary approach to control onchocersiasis-associated epilepsy in the Mahenge area in Morogoro region, Tanzania.From1 Jan 2018 → 31 Aug 2022Funding: VLIR-UOS TEAM
- Development of a policy to stop the suffering caused by Nodding Syndrome and Onchocerciasis associated epilepsy (NSstop).From1 Sep 2017 → 28 Feb 2019Funding: H2020 - Frontier Research (ERC)
- Nodding Syndrome: a trans-disciplinary approach to identify the cause and decrease the incidence of river epilepsy (NSETHIO).From1 Oct 2015 → 30 Nov 2021Funding: H2020 - Frontier Research (ERC)
- An investigation into the geographical distribution, host species, burden of disease and optimal diagnosis and treatment of Emmonsia hoerikwaggiana infections.From1 Jan 2014 → 31 Dec 2017Funding: FWO research project
Publications
21 - 30 of 310
- Onchocerciasis-associated epilepsy in Maridi, South Sudan(2023)
Authors: Samit Bhattacharyya, Natalie V.S.A. Vinkeles Melchers, Joseph Nelson Siewe Fodjo, Amit Vutha, Luc Coffeng, Makoy Logora, Robert Colebunders, Wilma Stolk
Pages: 1 - 17 - Methodological challenges for conducting case-control studies to investigate the association between onchocerciasis and epilepsy including nodding syndrome(2023)
Authors: Robert Colebunders, Amber Hadermann, Joseph Nelson Siewe Fodjo
Pages: 1 - 4 - Quality of life of persons with epilepsy in Mahenge, an onchocerciasis-endemic area in Tanzania(2023)
Authors: Luis-Jorge Teles de Meneses do Amaral, Dan Bhwana, Messaline F. Fomo, Bruno P. Mmbando, Carmen-Nabintu Chigoho, Robert Colebunders
Pages: 1 - 9 - Mortality among persons with epilepsy in onchocerciasis-endemic and non-endemic areas of sub-Saharan Africa(2023)
Authors: Joseph Nelson Siewe Fodjo, Gilles Van Cutsem, Luis-Jorge Teles de Meneses do Amaral, Robert Colebunders
Pages: 253 - 261 - Infectious Diseases Institute at Makerere University College of Health Sciences(2022)
Authors: Damalie Nakanjako, Barbara Castelnuovo, Nelson Sewamkambo, Tom Kakaire, Richard L. Brough, Elly T. Katabira, David L. Thomas, Thomas C. Quinn, Robert Colebunders, Warner C. Greene, et al.
Pages: 1 - 10 - Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission(2022)
Authors: Robert Colebunders, Christoph Kaiser, Maria-Gloria Basanez, Piero Olliaro, Tom Lakwo, Joseph Nelson Siewe Fodjo
Pages: 302 - 305 - Prevalence and risk factors associated with epilepsy in six health districts of Mali(2022)
Authors: Housseini Dolo, Fatoumata dite Nene Konipo, Fanta Sow, Fousseyni Kane, Modibo Sangare, Mariam Daou, Moussa Sangare, Oumar Sangho, Harouna Kone, Fousseyni D. Coulibaly, et al.
Pages: 127 - 137 - Using Andersen's model of health care utilization to assess factors associated with COVID-19 testing among adults in nine low-and middle-income countries(2022)
Authors: Supa Pengid, Karl Peltzer, Edlaine Faria Moura de Villela, Joseph Nelson Siewe Fodjo, Ching Sin Siau, Won Sun Chen, Suzanna A. Bono, Isareethika Jayasvasti, M. Tasdik Hasan, Rhoda K. Wanyenze, et al.
- The prevalence of onchocerciasis-associated epilepsy in Mundri west and east counties, South Sudan(2022)
Authors: Stephen Raimon Jada, Alfred Dusabimana, Gasim Abd-Elfarag, Samuel Okaro, Nele Brusselaers, Jane Y. Carter, Makoy Yibi Logora, Jacopo Mattia Rovarini, Charles R. Newton, Robert Colebunders
Pages: 1 - 17 - Cardiovascular risk factors and clinical outcomes of patients hospitalized with COVID-19 pneumonia in Somalia(2022)
Authors: Mohammed A.M. Ahmed, Ahmed Mohamud Hussein, Aweis Ahmed Moalim Abdullahi, Abdirizak Yusuf Ahmed, Hamdi M.A. Hussain, Abdiaziz Mohamed Ali, Abdulqadir Abdinur Barre, Farhia Mohamud Yusuf, Ronald Olum, Senai Goitom Sereke, et al.
Pages: 1 - 9
Linked dataset
1 - 2 of 2
- Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy : a randomized proof-of-concept clinical trial (Creator)
- Single versus multiple dose ivermectin regimen in onchocerciasis-infected persons with epilepsy treated with phenobarbital: a randomized clinical trial in the Democratic Republic of Congo (Creator)